Literature DB >> 25684250

Modified anterolateral approach in minimally invasive total hip arthroplasty.

Shang-Wen Tsai1, Cheng-Fong Chen, Po-Kuei Wu, Tain-Hsiung Chen, Chien-Lin Liu, Wei-Ming Chen.   

Abstract

PURPOSE OF THE STUDY: Minimally invasive procedures for total hip arthroplasty (THA) provide less surgery related trauma, and perhaps a fast recovery and satisfaction. Using modified instruments, we reported clinical follow-up data for a modified anterolateral approach. BASIC PROCEDURES: Using specialised retractors to expose the acetabulum and femur, this single-incision technique preserved more gluteus medius tendon and provided access for soft tissue repair. The demographic data for 1003 patients undergoing THA with this technique are presented, including operative variables, complications, Harris Hip Score for clinical evaluation and cup inclination angle for radiographic evaluation. Average follow-up was 59 months (range 24-121). MAIN
FINDINGS: In 1077 primary THAs performed in 1003 patients, the median wound length was 6 cm (range 4.8-9.2), median operation time was 68 minutes (range 45-112). The mean perioperative blood loss was 422 mls (range 56-990). The median cup inclination angle was 44 degrees (range 33-54), median acetabular version angle was 17° (range 12-24) median length of hospitalisation was 4 days (range 3-8). A total of 22 (2.0%) complications were noted including 5 cases of stem subsidence, 4 cup loosening, 5 greater trochanter fractures, 4 infections, 2 intraoperative proximal femur fractures and 2 iliopsoas impingement. In total, 13 (1.2%) received additional surgery. No neurovascular injury or dislocation was noted. For the clinical results, Harris Hip Score improved from 53 (range 33-67) preoperatively to 94 postoperatively (range 87-100). PRINCIPAL
CONCLUSIONS: Minimally invasive surgery via this modified anterolateral approach is a safe and reliable method.

Entities:  

Mesh:

Year:  2015        PMID: 25684250     DOI: 10.5301/hipint.5000218

Source DB:  PubMed          Journal:  Hip Int        ISSN: 1120-7000            Impact factor:   2.135


  6 in total

1.  Limited benefits of the direct anterior approach in primary hip arthroplasty: A prospective single centre cohort study.

Authors:  Jetse Jelsma; Rik Pijnenburg; Harm W Boons; Peter J M G Eggen; Lucas L A Kleijn; Herman Lacroix; Hub J Noten
Journal:  J Orthop       Date:  2016-10-26

2.  Lateral versus conventional fasciotomy for prevention of lateral femoral cutaneous nerve injury in total hip arthroplasty with direct anterior approach: a study protocol for a dual-center, double-blind, randomized controlled trial.

Authors:  Hiroki Tanabe; Tomonori Baba; Yu Ozaki; Naotake Yanagisawa; Sammy Banno; Taiji Watari; Yasuhiro Homma; Masashi Nagao; Kazuo Kaneko; Muneaki Ishijima
Journal:  Trials       Date:  2022-07-15       Impact factor: 2.728

3.  Pharmacological thromboprophylaxis as a risk factor for early periprosthetic joint infection following primary total joint arthroplasty.

Authors:  Fu-Yuan Pai; Wei-Lin Chang; Shang-Wen Tsai; Cheng-Fong Chen; Po-Kuei Wu; Wei-Ming Chen
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

4.  Supercapsular percutaneously assisted total hip arthroplasty versus conventional posterior approach: Comparison of early functional results.

Authors:  Heng Jiang; Li-Hong Wang; Yong-Xin Jin; Zhi-Ming Liu; Liang-Feng Xu; Xian-Yun Chen
Journal:  Acta Orthop Traumatol Turc       Date:  2020-09       Impact factor: 1.511

5.  Acetabular cup orientation and postoperative leg length discrepancy in patients undergoing elective total hip arthroplasty via a direct anterior and anterolateral approaches.

Authors:  Ronen Debi; Evyatar Slamowicz; Ornit Cohen; Avi Elbaz; Omri Lubovsky; Dror Lakstein; Zachary Tan; Ehud Atoun
Journal:  BMC Musculoskelet Disord       Date:  2018-06-08       Impact factor: 2.362

6.  A comparison of leg length discrepancy between direct anterior and anterolateral approaches in total hip arthroplasty.

Authors:  Henry Dunn; Geoff Rohlfing; Robert Kollmorgen
Journal:  Arthroplasty       Date:  2020-11-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.